NCT06940518
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Ivonescimab
Explore clinical trials studying Ivonescimab. Study availability and eligibility vary by location and protocol.
6 public trials
3 recruiting studies
Ivonescimab trial results
NCT07686575
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +9 more
- Locations
-
- Department of Stomatology, Zhujiang Hospital, Southern Medical University, Haizhu District, Guangzhou Guangzhou, Guangdong, China
- Department of Stomatology, Zhujiang Hospital, Southern Medical University,Haizhu District Guangzhou, Guangdong, China
NCT07385001
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
- Locations
-
- Tangdu Hospitial Xi'an, Shannxi, China
Not yet recruiting
A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)
NCT07753824
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Appendiceal Adenocarcinoma, +10 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT07743138
- Conditions
- ACC, Adenocarcinoma, Adrenal Cortex Diseases, +17 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Not yet recruiting
AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer
NCT07021950
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
- Locations
-
Not specified